CoChat

The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes

Khan, A. S. A., McLoughney, C. R., Ahmed, A. B. · 2006 · Diabetic Medicine
Cited by 58

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims In a randomized, double‐blind, cross‐over study, we investigated the effect of metformin on blood glucose control and daily insulin dose in overweight patients with Type 1 diabetes. Methods We studied 15 C‐peptide‐negative patients, aged 48 ± 12 years, with a body mass index of 31.3 ± 2.6 kg/m 2. Each patient had a ‘screening visit’, followed by a 4‐week ‘run‐in’ period. This was followed by two separate 16‐week ‘study’ (treatment) periods, separated by a 4‐week ‘wash‐out’ period. Patients received either metformin or placebo during the ‘study’ periods, in random order. Results HbA 1c was significantly lower following 16 weeks of treatment with metformin (7.8 ± 1.1%) compared with baseline (8.5 ± 1.4%; P < 0.005) and placebo (8.6 ± 1.2%; P < 0.005). Fasting plasma glucose, following 16 weeks of metformin treatment, was significantly lower (8.3 ± 2.8 mmol/l) compared with baseline (12.4 ± 3.0 mmol/l; P < 0.01) and placebo (12.6 ± 3.4 mmol/l; P < 0.01). Compared with baseline (60 ± 14 units), total daily insulin dose was significantly lower following the addition of metformin (50 ± 13 units; P < 0.05) and this final total daily insulin dose in the metformin group was lower compared with placebo (58 ± 12 units, P < 0.05). Body weight did not change following metformin or placebo treatment. Conclusion Metformin can effectively improve glycaemic control and reduce the total daily insulin dose in overweight people with Type 1 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2006.01966.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 58

Metadata

Authors
Khan, A. S. A., McLoughney, C. R., & Ahmed, A. B.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2006-09-14
Volume
23
Issue
10
Pages
1079-1084
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1982803765
Cited by
58
References
4
FWCI
2.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.